🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesBlood sugar used to spike to 200 after meals, now barely hits 120 — what worked for you? Page 3

Blood sugar used to spike to 200 after meals, now barely hits 120 — what worked for you?

SallyK_inj Mon, Feb 2, 2026 at 2:16 AM 28 replies 1,338 viewsPage 3 of 6
DebRD_ATL
Senior Member
1,678
7,890
Feb 2024
Atlanta, GA
Feb 7, 2026 at 6:38 AM#11
chris_chi24 said:
Insulin sensitivity test (HOMA-IR) on glycaemic control — arguably the most important metabolic marker most people aren't tracking: HOMA-IR = (fasting…

Agreed, and the size of the effect matters as much as its existence. Something real and small gets treated here as though it were real and decisive.

50 23BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 47 others
Reply Quote Save Share Report
steph_laguna
Member
234
1,123
Nov 2024
Laguna Beach, CA
Feb 7, 2026 at 11:11 PM#12
bri_stats said:
Patient selection optimization for glycaemic control: emerging predictive biomarkers for GLP-1 agonist response include: Biomarker Association…

That reframing is the part I needed. Printing the relevant bit and taking it with me.

1 24GraceAZ_72
Reply Quote Save Share Report
Dr.LeslieOBGYN
Member
567
2,567
May 2024
Dallas, TX
Feb 8, 2026 at 3:44 PM#13
chris_chi24 said:
Insulin sensitivity test (HOMA-IR) on glycaemic control — arguably the most important metabolic marker most people aren't tracking: HOMA-IR = (fasting…

Careful with the causal language. Two things moving together in a period when five things changed is not a mechanism, and stating it as one makes the thread less useful to somebody reading it later.

2 0james_edin, FranDenver
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Feb 9, 2026 at 8:17 AM#14

One concrete data point for the thread. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.

3 1amsterdam_pete, LondonLisa, mike_nyc
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Feb 10, 2026 at 12:49 AM#15

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Carry on.

Last edited: Feb 10, 2026 at 4:49 AM
4 2PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 1 other
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register